India
· Delayed Price · Currency is INR Aurobindo Pharma Company Description
Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.
The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology.
It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams.
The company was incorporated in 1986 and is headquartered in Hyderabad, India.
| Country | India |
| Founded | 1986 |
| Industry | Pharmaceutical Preparations |
| Employees | 26,015 |
| CEO | Kambam Reddy |
Contact Details
Address: Galaxy, Plot No. 1 Hyderabad, 500032 India | |
| Phone | 91 40 6672 5000 |
| Website | aurobindo.com |
Stock Details
| Ticker Symbol | 524804 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kambam Reddy | Chief Executive Officer |
| Santhanam Subramanian | Chief Financial Officer |